Back to company

EJP PHARMACEUTICAL ApS: Financial statements 2016

CVR: 87923614

EJP PHARMACEUTICAL ApS (CVR 87923614) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK -124,461 and a net result of DKK -1,585,406 compared with DKK 1,560,353 the year before. Equity amounted to DKK 8,569,930. The solvency ratio was 98.6%.

Gross Profit
-124,461 kr.
Profit/Loss
-1,585,406 kr.
Equity
8,569,930 kr.
Total Assets
8,692,734 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2016--124 t.-1.6 mio.8.6 mio.-
2015--161 t.1.6 mio.10.2 mio.-
2014--221 t.642 t.8.6 mio.-
2013--395 t.1.2 mio.8.5 mio.-
2012--648 t.2.6 mio.27.2 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is EJP PHARMACEUTICAL ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2016

EJP PHARMACEUTICAL ApS: The 2015 annual report is outMay 27, 2016

EJP PHARMACEUTICAL ApS has published its annual report for 2015. Gross profit came to DKK -161,302, and the net result was DKK 1,560,353.

Auditor steps down at EJP PHARMACEUTICAL ApSMay 25, 2016

As of May 25, 2016, RSM PLUS P/S STATSAUTORISEREDE REVISORER has stepped down as auditor of EJP PHARMACEUTICAL ApS.

About EJP PHARMACEUTICAL ApS

EJP PHARMACEUTICAL ApS is a Danish company of the type Anpartsselskab based in Skodsborg, founded in 1982. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Ejvind Jersie Pedersen. The company is owned by Ejvind Jersie Pedersen. The company has 1 employee. In 2025, the company reported a gross profit of DKK -28,266 and a net result of DKK 214,282 compared with DKK 414,071 the year before. Equity amounted to DKK 814,282.